The Davis Group develops and applies methods for the design, analysis and manipulation of functional molecular interfaces (bioelectronic, biochemical, wires, mechanically interlocked, nanoparticles), often at molecular scales, and are actively engaged in the use and development of state of the art molecular, theranostic and medical imaging technologies.
Current projects include:
MOLECULAR SWITCHES & SENSORS: The development of methods to trigger & follow dynamic motion in emissive surface assembled "molecular shuttles". Switching electron transfer or optical outputs, for example.
NANOPARTICLE THERANOSTICS: The design and synthesis of responsive MRI contrast agents & cargo delivery systems.
MOLECULAR FILMS & ELECTRON TRANSFER ANALYSES: Tuning electron transfer interfaces and the development of fundamental methods in impedance technology.
DIAGNOSTICS: The development of highly effective protocols for assaying disease biomarkers, including those of generic clinical value (C-Reactive Protein, Insulin) and those affiliated with Parkinsons Disease.
See the main group web site for more detail.
The groups research activities are sponsored by the EU, EPSRC, BBSRC, Wellcome Trust, The Royal Society, The British Council, The Leverhulme Trust and Parkinsons UK.